Navigation Links
Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
Date:12/5/2012

BALTIMORE, Dec. 5, 2012 /PRNewswire/ -- Cerecor Inc today announced that it has signed an option with Johns Hopkins University (JHU) for an exclusive license to develop and commercialize small molecule D-Amino Acid Oxidase inhibitors ("DAAO inhibitors") that were developed at the Johns Hopkins Brain Science Institute ("BSi").

(Logo: http://photos.prnewswire.com/prnh/20120411/PH85852LOGO )

DAAO inhibitors inhibit the degradation of D-serine, an amino acid which has a central role in the normal function of the glutamate / NMDA system in the human brain.  Growing evidence suggests that deficits in glutamate transmission are central to the neurobiology of schizophrenia.  D-serine, when administered in multi-gram quantities per day, has been shown in multiple studies to improve cognition (executive function) and reduce positive symptoms in schizophrenics. DAAO inhibition in the brain, as a means of increasing D-serine levels, has been a target for treating schizophrenia by major pharmaceutical companies for many years. 

"This approach to improving glutamate transmission is to administer DAAO inhibitors systemically along with small, supplemental doses of D-serine, in a simple and elegant fashion analogous to the use of Sinemet® for the treatment of Parkinson's Disease, as originally conceptualized by Drs. Solomon Snyder and Barbara Slusher," said Dr. Blake Paterson, co-founder and CEO of Cerecor. "The licensing of the DAAO inhibitor platform will be an important milestone in the development of a novel therapeutic for schizophrenic patients, for whom persistent cognition dysfunction is widely recognized as an important gap in current therapeutic approaches."

Under the terms of the agreement with JHU, Cerecor will fund final lead selection efforts already underway at the BSi via a sponsored research agreement. Under the terms of the agreement, once
'/>"/>

SOURCE Cerecor Inc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dr. Magnus Persson Joins Cerecors Board of Directors
2. Cerecor Announces Initiation of CLIN01-002-A
3. Savient Announces the Election of Robert G. Savage to its Board of Directors
4. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
5. Braincells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Companys Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression
6. Tria Beauty, Inc. Announces Partnership with Jenny McCarthy
7. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
8. UBM Canon Announces its New Medical Technology Seminar Series
9. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
10. Perrigo Company Announces The Appointment Of Industry Veteran To Executive Vice President And General Manager, Rx
11. Ultra Clean Announces Participation in the Midtown CAP Summit Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 22, 2014  Sprout Pharmaceuticals today announced ... demonstrate that women treated with flibanserin up to 200 mg ... data were presented at the 20 th Annual Fall ... North America in Miami . ... response to the Complete Response Letter and the Formal Dispute ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/21/2014)... -- Alere Inc. (NYSE: ALR ), a global ... Cunningham as Vice President, Investor Relations. In this ... communications with the investment community. "As we ... increase shareholder value, it is critical that we effectively ... Executive Officer. "We are delighted that Juliet Cunningham ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... SAN DIEGO, March 3, 2011 WHO:   , Awarepoint ... Cowen and Company 31st Annual Health Care Conference taking place ... Wednesday, March 9, 2011. Awarepoint is scheduled to present on ... Cowen and Company,s conferences are major industry events attracting ...
... part of its ongoing mission to serve cancer patients, ... launch of its enhanced website that provides cancer patients, ... spanning cancer prevention, education, patient care, advocacy, and financial ... a powerful new cancer resource navigator tool developed to ...
Cached Medicine Technology:Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 2Awarepoint Invited to Present at Cowen & Company 31st Annual Health Care Conference 3Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 2Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients 3
(Date:11/24/2014)... SweetDressy.com, a well-known dress supplier and leader in the ... Dresses. All these fresh items are offered at affordable ... special offer is valid until Dec. 20, 2014. Click ... working well in the fashion industry for years. They ... dresses may be the best products for many ladies ...
(Date:11/24/2014)... November 24, 2014 Mental health ... day. They break up families, ruin careers, and ... hope for those that suffer,” says Hardy ... is showing that our specialized nutritional treatments can ... appear on “Mind Over Matter”, the premiere episode ...
(Date:11/24/2014)... CO, and Philadelphia, PA (PRWEB) November 24, 2014 ... provider of care coordination and disease management services ... has chosen to implement Essette’s Medical Management software ... new Essette SaaS platform in a program to ... Essette suite includes Population Health Management, Care Management, ...
(Date:11/24/2014)... "My friend was killed when a vehicle struck ... in his motorized wheelchair," said an inventor from Southfield, ... with this idea so that people in wheelchairs would ... Safety Lites to make a wheelchair highly visible, especially ... that motorists can see the wheelchair. This helps reduce ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... important one: The number of babies who die of SIDS, ... New Year,s Day. The suspected reason? Alcohol consumption by caretakers ... the University of California, San Diego, the study documenting the ... in the journal Addiction . The spike, write Phillips ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Dec. 15 ... confirm a brain death diagnosis is not only unnecessary but may ... their loved one,s organs, a new study finds. Researchers reviewed ... adults and 82 children who had been declared brain dead. All ...
... HOUSTON - The recently identified TRIM24 protein plays an ... cell proliferation and, potentially, into breast cancer. Reporting ... by researchers at The University of Texas MD Anderson ... estrogen-responsive genes toward active expression. This expression, in turn, ...
... American Society for Radiation Oncology (ASTRO) has received a ... www.rtanswers.org . , The Web Health Awards is a ... 500 entries were submitted for the 2010 competition from ... were selected by a panel of national electronic health ...
... , WEDNESDAY, Dec. 15 (HealthDay News) -- People,s happiness ... study suggests. Researchers examined the link between economic ... of 10 years and an average of 22 years. ... poor, ex-Communist and capitalist. The findings challenge "recent ...
... at Virginia Commonwealth University Massey Cancer Center and the VCU ... gene therapy for renal cell carcinoma that has been shown ... site but also in distant tumors not directly infected by ... of kidney cancer in adults and currently there is no ...
Cached Medicine News:Health News:SIDS spikes on New Year's Day 2Health News:Second Brain Death Exam Unnecessary, Study Finds 2Health News:Second Brain Death Exam Unnecessary, Study Finds 3Health News:Protein disables p53, drives breast cells toward cancer transition 2Health News:Protein disables p53, drives breast cells toward cancer transition 3Health News:Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center 2
For the quantitative determination of apolipoprotein B (apo B) in serum and plasma....
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: